Avidity Biosciences, Inc. RNA
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Keay Nakae | Chardan Capital | 70 $ | 72 $ | 2.00 % | 28/10/2025 |
| Luca Issi | RBC Capital | 70 $ | 72 $ | 2.00 % | 28/10/2025 |
| Keay Nakae | Loop Capital Markets | 70 $ | 72 $ | 2.00 % | 28/10/2025 |
| Market Perform | Leerink Partners | 69.945 $ | 72 $ | 2.06 % | 27/10/2025 |
| Boobalan Pachaiyappan | Roth Capital | 49.15 $ | 72 $ | 22.85 % | 27/10/2025 |
| Market Perform | Bernstein | 49.15 $ | 72 $ | 22.85 % | 27/10/2025 |
| Eric Schmidt | Cantor Fitzgerald | 46.4 $ | 96 $ | 49.60 % | 10/09/2025 |
| Gavin Clark-Gartner | Evercore ISI | 31.45 $ | 70 $ | 38.55 % | 11/07/2025 |
| Corinne Johnson | Goldman Sachs | 43.5 $ | 59 $ | 15.50 % | 24/09/2024 |
| Yanan Zhu | Wells Fargo | 28.92 $ | 50 $ | 21.08 % | 12/06/2024 |